CONTACT
CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
Code
Product Name
Price
Buy
SP-Ab-12_0.1
A21G-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-12_0.5
A21G-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-28_0.1
A2T-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-28_0.5
A2T-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.1
A2T-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.5
A2T-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-27_0.1
A2V-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-27_0.5
A2V-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.1
A2V-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.5
A2V-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-20_0.1
Beta-Amyloid (1-37); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-20_0.5
Beta-Amyloid (1-37); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.1
Beta-Amyloid (1-38); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.5
Beta-Amyloid (1-38); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-32-0.1
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-32-0.5
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-18_0.1
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.1mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-18_0.5
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.5mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.1
Beta-Amyloid (1-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.5
Beta-Amyloid (1-40); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-31-0.1
Beta-Amyloid (1-42) Scrambled; HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-31-0.5
Beta-Amyloid (1-42) Scrambled; HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-16_0.1
Beta-Amyloid (1-42)-Lys(Biotinoyl); HFIP treated (0.1mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-16_0.5
Beta-Amyloid (1-42)-Lys(Biotinoyl); HFIP treated (0.5mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-07_0.1
Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-07_0.5
Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-08_0.1
Beta-Amyloid (1-43); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-08_0.5
Beta-Amyloid (1-43); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-22_0.1
Beta-Amyloid (17-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-23_0.5
Beta-Amyloid (17-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-19_0.1
Biotinoyl-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-19_0.5
Biotinoyl-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-17_0.1
Biotinoyl-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-17_0.5
Biotinoyl-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-15_0.1
D23N-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
SP-Ab-15_0.5
D23N-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
SP-Ab-09_0.1
D7N-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
SP-Ab-09_0.5
D7N-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
Loading. Please wait
News
Do you perform T-cell ELISPOT Assays?
JPT supports Immudex annual Elispot Proficiency Panel 2020.
(February 2020)
Quality Assurance
All production is performed according to ISO 9001:2015 standards.
